EUVIMEDEUVIMED entdecken
Crossref

EUS-guided pancreatic duct drainage: endoscopic and clinical practice experience

M. Marasco, S. Godat, B. Annibale, F. Panzuto, D. Galasso

Endoscopy · 01.04.2024 · 56 (S 02 S 02) · S390

DOI: 10.1055/s-0044-1783665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Endoscopy, erschienen am 01.04.2024. Verfasst von M. Marasco und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

EUS-guided pancreatic duct drainage (EUSPDD) is an endoscopic procedure which is indicated in symptomatic patients with evidence of pancreatic duct obstruction after failure of transpapillary drainage or impossibility to perform EWSL in the contest of chronic pancreatitis or altered anatomy causes (e.g. Whipple or Roux-en-Y surgery). Nowadays, it is a challenging procedure performed by few endoscopist. Clinical and technical success rate is still lacking and heterogenous, therefore acquisition of new data and experience is necessary.

Methods

This is a retrospective observational single-center study including patients undergone EUSPDD from March 2018 to July 2023 using plastic stent (7Fr 10cm), delivered with an electrocautery-enhanced catheter, after transpapillary drainage failure. Also, it was evaluated exocrine pancreatic function by fecal elastase (FE-1) and nutritional markers (prealbumin and magnesium).

Results

Total of 15 patients (M:F=11:4) with median age of 72 years old. 13 patients (86.6%) had a chronic pancreatitis diagnosis with radiological evidence of duct pancreatic alterations (5 stenosis, 3 lithiasis, 4 both, 1 duct rupture); 2 patients had a post-surgical stenosis. All patients were symptomatic: 6 patients (40%) shows multiple episodes of acute pancreatitis and 9 (60%) had abdominal pain non responder to medical therapy. Pancreatic duct had median dilatation of 7 mm (4-15.6 mm). Every transmural access was performed through gastric wall with single plastic stent (7Fr 10cm) placement. Technical success was obtained in 11 patients (73%), 2 patients (13.3%) had early stent migration and in 4 patients (26.6%) EUSPDD was failed. No other adverse events. 13 patients (86.6%) had a condition of pancreatic exocrine insufficiency with FE-1

Zitieren

APA

Marasco, M., Godat, S., Annibale, B., Panzuto, F., & Galasso, D. (2024). EUS-guided pancreatic duct drainage: endoscopic and clinical practice experience. Endoscopy, 56(S 02 S 02), S390. https://doi.org/10.1055/s-0044-1783665

Vancouver

Marasco M, Godat S, Annibale B, Panzuto F, Galasso D. EUS-guided pancreatic duct drainage: endoscopic and clinical practice experience. Endoscopy. 2024;56(S 02 S 02):S390. doi:10.1055/s-0044-1783665

BibTeX
@article{Marasco2024,
  author = {Marasco, M. and Godat, S. and Annibale, B. and Panzuto, F. and Galasso, D.},
  title = {EUS-guided pancreatic duct drainage: endoscopic and clinical practice experience},
  journal = {Endoscopy},
  year = {2024},
  volume = {56},
  number = {S 02 S 02},
  pages = {S390},
  doi = {10.1055/s-0044-1783665}
}
Kostenlos starten →